Drug
Ulonivirine clinical trials
Also written MK-8507.
Keep track of what changes. Save the ulonivirine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- ULO
- 3
Development codes
Studies by the year they started
9 studies that test it; most in 2025 (3); 1 more planned to start later
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Islatravir (4) · Atorvastatin (1) · Metformin (1) · Moxifloxacin (1) · Methadone (1)
Studies
Open first, then newest update. How each study uses ulonivirine is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)RecruitingPhase 2/3Merck Sharp & Dohme LLCNCT07266831Written as ULO
- A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)RecruitingPhase 1Merck Sharp & Dohme LLCNCT07595263Written as Ulonivirine
- Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)Not yet recruitingPhase 1Merck Sharp & Dohme LLCNCT05093972Written as Ulonivirine
- A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)CompletedPhase 1Merck Sharp & Dohme LLCNCT07530289Written as Ulonivirine
- A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)CompletedPhase 1Merck Sharp & Dohme LLCNCT07305831Written as Ulonivirine
- Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]CompletedPhase 2Merck Sharp & Dohme LLCNCT04564547Written as Ulonivirine
- A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)CompletedPhase 1Merck Sharp & Dohme LLCNCT07334886Written as [14C]Ulonivirine
- A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)Active, not recruitingPhase 2Merck Sharp & Dohme LLCNCT06891066Written as ULO
- A Study of MK-8507 and Islatravir (MK-8591) in Healthy Adult Participants (MK-8507-016)CompletedPhase 1Merck Sharp & Dohme LLCNCT06619678Written as MK-8507
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)CompletedPhase 1Merck Sharp & Dohme LLCNCT02174159Written as Ulonivirine
Codes
What other systems call ulonivirine · ClinicalTrials.gg INT001929
- MeSH (NLM) C000723084ulonivirineOne source ClinicalTrials.gov
- UNII (FDA) 4NS011EGKZULONIVIRINEOne source FDA
- NCI Thesaurus C190365UlonivirineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000723084 | ulonivirine | One source ClinicalTrials.gov |
| UNII (FDA) | 4NS011EGKZ | ULONIVIRINE | One source FDA |
| NCI Thesaurus | C190365 | Ulonivirine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.